½ÃÀ庸°í¼­
»óǰÄÚµå
1771502

¹Ì±¹ÀÇ ¼Òº¯ °Ë»ç ÄÅ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ¸ê±Õº°, Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, ºÎ¹® ¿¹Ãø(2025-2030³â)

U.S. Urine Testing Cups Market Size, Share & Trends Analysis Report By Sterility (Sterile, Non-Sterile), By Product (With Temperature Strip, Without Temperature Strip), By Application (Drug Testing), By End-use, And Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 140 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¹Ì±¹ÀÇ ¼Òº¯ °Ë»ç ÄÅ ½ÃÀå µ¿Çâ :

¹Ì±¹ÀÇ ¼Òº¯ °Ë»ç ÄÅ ½ÃÀå ±Ô¸ð´Â 2024³â 3¾ï 9,000¸¸ ´Þ·¯·Î Ãß°èµÇ¸ç, 2025-2030³â¿¡ °ÉÃÄ CAGR 6.46%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀǾàǰ ³²¿ëÀÇ Áõ°¡, Áúº´ Áø´Ü ¹× ¸¸¼º Áúȯ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ »ç¿ë Áõ°¡, ±â¼ú ¹ßÀü, ÇöÀå Áø·á ¹× °¡Á¤¿ë Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä È®´ë µîÀ¸·Î ¼Òº¯ °Ë»ç ÄÅ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¹Ì±¹ÀÇ ¼Òº¯ °Ë»ç ÄÅ »ê¾÷Àº ¸î °¡Áö ÁÖ¿ä ¿äÀÎÀÇ ÃßÁøÀ¸·Î °­·ÂÇÑ ¼ºÀåÀ» º¸À̰í ÀÖ½À´Ï´Ù. ´ç´¢º´, ½ÅÀå Áúȯ, ¿ä·Î °¨¿° µî ¸¸¼º ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó È¿°úÀûÀÎ Áúº´ °ü¸®¸¦ À§ÇØ Á¤±âÀûÀÎ ¼Òº¯ °Ë»ç°¡ ÇÊ¿äÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â ¹Ì±¹ ´ç´¢º´ Çùȸ º¸°í¼­¿¡ µû¸£¸é ¹Ì±¹¿¡¼­ 3800¸¸ ¸í ÀÌ»óÀÇ ¾î¸°ÀÌ¿Í ¼ºÀÎÀÌ ´ç´¢º´À» ¾Î°í ÀÖ½À´Ï´Ù.

ÀÚµ¿ ºÐ¼®±â ¹× ½º¸¶Æ®Æù ȣȯ Å×½ºÆ® ½ºÆ®¸³ÀÇ °³¹ßÀ» ºñ·ÔÇÑ ±â¼úÀÇ ¹ßÀüÀ¸·Î ¼Òº¯ °Ë»çÀÇ Á¤È®¼º°ú ÆíÀǼºÀÌ Çâ»óµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, ÇöÀå Áø·á ¹× °¡Á¤¿ë Áø´Ü ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 ¿¹¹æ ÀÇ·á ¹× ¸ÂÃãÇü ÀǾàǰ¿¡ ´ëÇÑ ±¤¹üÀ§ÇÑ Æ®·»µå¿Íµµ ºÎÇÕÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ Á¾ÇÕÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ¹Ì±¹ ³» ´Ù¾çÇÑ ÀÇ·á ½Ã¼³¿¡¼­ ¼Òº¯ °Ë»ç ÄÅÀÇ »ç¿ëÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

2025³â 2¿ù ¹Ì±¹ ½ÅÀå Àç´Ü(American Kidney Fund)ÀÌ ¾÷µ¥ÀÌÆ®ÇÑ µ¥ÀÌÅÍ¿¡ µû¸£¸é, ¾à 3,550¸¸ ¸íÀÇ ¹Ì±¹ÀÎÀÌ ½ÅÀå ÁúȯÀ» ¾Î°í ÀÖÀ¸¸ç, ±× Áß ¾à 55¸¸ 5,000¸íÀÌ Åõ¼®À» ¹Þ°í ÀÖ°í, ¾à 81¸¸ 5,000¸íÀÌ ½ÅºÎÀüÁõÀ» ¾Î°í ÀÖ½À´Ï´Ù. ¸¸¼º ½ÅÀå ÁúȯÀÇ ±Þ°ÝÇÑ Áõ°¡ ´Â Áúº´ Á¶±â ¹ß°ß°ú Àå±â °Ç°­ ¸ð´ÏÅ͸µÀ» À§ÇÑ ¼Òº¯ °Ë»ç ÀÇÁ¸µµ°¡ ³ô¾ÆÁö°í ÀÖÀ½À» º¸¿©ÁÝ´Ï´Ù. ¼Òº¯ °Ë»ç ¿ë±â´Â ½ÅÀå ±â´É Àå¾ÖÀÇ Ãʱâ Áõ»óÀ» ½Äº°ÇÏ´Â ´Ü¼øÇÏ°í ºñħ½ÀÀûÀÌ¸ç ºñ¿ë È¿À²ÀûÀÎ ¹æ¹ýÀ» Á¦°øÇÏ¿© Àû½Ã ÀÇ·á °³ÀÔÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ½ÅÀå ÁúȯÀÌ ¹Ì±¹ ¼ºÀÎ Àα¸ÀÇ 14% ÀÌ»óÀ» ¿µÇâÀ» ¹ÌÄ¡¸ç, ƯÈ÷ À¯»ö ÀÎÁ¾ Ä¿¹Â´ÏƼ¿¡ ºÒ±ÕÇüÀûÀ¸·Î ¿µÇâÀ» ¹ÌÄ¡´Â »óȲ¿¡¼­ Á¤±âÀûÀÎ °ËÁø µµ±¸ÀÎ ¼Òº¯ °Ë»ç ¿ë¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â±â´Â ¸¸¼º Áúȯ °ü¸® ¹× ¿¹¹æ ÀÇ·á ÀÌ´Ï¼ÅÆ¼ºê ÃßÁø¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¹Ì±¹ÀÇ ¼Òº¯ °Ë»ç ÄÅ ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅëÀÇ Àü¸Á
    • ¸ð ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
    • ½ÃÀå ±âȸ ºÐ¼®
    • ½ÃÀå °úÁ¦ ºÐ¼®
  • ¹Ì±¹ÀÇ ¼Òº¯ °Ë»ç ÄÅ ½ÃÀå ºÐ¼® µµ±¸
    • ¾÷°è ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå ¹Ì±¹ÀÇ ¼Òº¯ °Ë»ç ÄÅ ½ÃÀå : ¸ê±Õº° ÃßÁ¤ ¹× µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ÀÇ ¼Òº¯ °Ë»ç ÄÅ ½ÃÀåÀÇ º¯µ¿ ºÐ¼®
  • ¹Ì±¹ÀÇ ¼Òº¯ °Ë»ç ÄÅ ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м® : ¸ê±Õº°(2018-2030³â)
  • ¸ê±Õ
  • ºñ¸ê±Õ

Á¦5Àå ¹Ì±¹ÀÇ ¼Òº¯ °Ë»ç ÄÅ ½ÃÀå : Á¦Ç°º° ÃßÁ¤ ¹× µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ÀÇ ¼Òº¯ °Ë»ç ÄÅ ½ÃÀåÀÇ º¯µ¿ ºÐ¼®
  • ¹Ì±¹ÀÇ ¼Òº¯ °Ë»ç ÄÅ ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м® : Á¦Ç°º°(2018-2030³â)
  • ¿Âµµ ½ºÆ®¸³ Æ÷ÇÔ
  • ¿Âµµ ½ºÆ®¸³ ¹ÌÆ÷ÇÔ

Á¦6Àå ¹Ì±¹ÀÇ ¼Òº¯ °Ë»ç ÄÅ ½ÃÀå : ¿ëµµº° ÃßÁ¤ ¹× µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ÀÇ ¼Òº¯ °Ë»ç ÄÅ ½ÃÀåÀÇ º¯µ¿ ºÐ¼®
  • ¹Ì±¹ÀÇ ¼Òº¯ °Ë»ç ÄÅ ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м® : ¿ëµµº°(2018-2030³â)
  • ¾à¹° °Ë»ç
  • ÀӽŠ°Ë»ç
  • Áúº´ °ËÃâ

Á¦7Àå ¹Ì±¹ÀÇ ¼Òº¯ °Ë»ç ÄÅ ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ÃßÁ¤ ¹× µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ÀÇ ¼Òº¯ °Ë»ç ÄÅ ½ÃÀåÀÇ º¯µ¿ ºÐ¼®
  • ¹Ì±¹ÀÇ ¼Òº¯ °Ë»ç ÄÅ ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м® : ÃÖÁ¾ ¿ëµµº°(2018-2030³â)
  • º´¿ø ¹× Áø·á¼Ò
  • Áø´Ü½ÇÇè½Ç
  • °¡Á¤
  • ±âŸ

Á¦8Àå °æÀï ±¸µµ

  • ½ÃÀå ÁøÃâ±â¾÷ÀÇ ºÐ·ù
  • ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • BD
    • Abbott
    • Labcon North America
    • Quest Diagnostics
    • Confirm BioSciences
    • Alfa Scientific Designs, Inc.
    • Medline Industries, LP
    • Globe Scientific Inc
    • CLIAWAIVED
    • Clarity Diagnostics, LLC
    • SARSTEDT AG & Co. KG
    • Wondfo
  • ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®(2024³â)
  • ±âŸ ÁÖ¿ä ½ÃÀå ±â¾÷ ¸ñ·Ï
HBR 25.07.23

U.S. Urine Testing Cups Market Trends:

The U.S. urine testing cups market size was estimated at USD 0.39 billion in 2024 and is projected to grow at a CAGR of 6.46% from 2025 to 2030. The demand for urine testing cups is increasing due to the rising prevalence of drug abuse, growing use in disease detection and chronic condition monitoring, technological advancements, and the expanding need for point-of-care and home-based diagnostics.

The U.S. urine testing cups industry is experiencing robust growth, propelled by several key factors. The increasing prevalence of chronic conditions such as diabetes, kidney disease, and urinary tract infections necessitates regular urinalysis for effective disease management. For instance, according to the American Diabetes Association report published in 2023, over 38 million children and adults have diabetes in the U.S. In addition, according to the same source, over the past decade, the national healthcare costs related to diabetes have risen by USD 80 billion, climbing from USD 227 billion in 2012 to USD 307 billion in 2022. As a result, growing cases of diabetes and rising healthcare costs related to diabetes are expected to further fuel the market growth.

Technological advancements, including the development of automated analyzers and smartphone-compatible test strips, have enhanced the accuracy and convenience of urine testing. Moreover, the rising demand for point-of-care and home-based diagnostic tools aligns with the broader trend toward preventive healthcare and personalized medicine. These factors collectively contribute to the expanding adoption of urine testing cups across various healthcare settings in the U.S.

According to data updated by the American Kidney Fund in February 2025, approximately 35.5 million Americans are living with kidney disease, with nearly 555,000 undergoing dialysis and about 815,000 experiencing kidney failure. This significant rise in chronic kidney conditions underscores the growing reliance on urine testing for disease detection and long-term health monitoring. Urine testing cups provide a simple, non-invasive, and cost-effective method for identifying early signs of kidney dysfunction, enabling timely medical intervention. With kidney disease now affecting over 14% of American adults-and disproportionately impacting communities of color-the demand for regular screening tools like urine testing cups is rising. These devices play a critical role in managing chronic conditions and advancing preventive healthcare initiatives.

U.S. Urine Testing Cups Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. urine testing cups market report based on sterility, product, application, and end use:

  • Sterility Outlook (Revenue, USD Million, 2018 - 2030)
  • Sterile
  • Non-Sterile
  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • With Temperature Strip
  • Without Temperature Strip
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Drug Testing
  • Pregnancy Testing
  • Disease Detection
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Use
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Urine Testing Cups Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenge analysis
  • 3.3. U.S. Urine Testing Cups Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. U.S. Urine Testing Cups Market: Sterility Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Urine Testing Cups Market Movement Analysis
  • 4.3. U.S. Urine Testing Cups Market Size & Trend Analysis, by Sterility, 2018 to 2030 (USD Million)
  • 4.4. Sterile
    • 4.4.1. Sterile market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Non-Sterile
    • 4.5.1. Non-Sterile market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. U.S. Urine Testing Cups Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Urine Testing Cups Market Movement Analysis
  • 5.3. U.S. Urine Testing Cups Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 5.4. With Temperature Strip
    • 5.4.1. With temperature strip market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Without Temperature Strip
    • 5.5.1. Without temperature strip market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. U.S. Urine Testing Cups Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Urine Testing Cups Market Movement Analysis
  • 6.3. U.S. Urine Testing Cups Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Drug Testing
    • 6.4.1. Drug testing market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5. Pregnancy Testing
    • 6.5.1. Pregnancy testing market estimates and forecast 2018 to 2030 (USD Million)
  • 6.6. Disease Detection
    • 6.6.1. Disease detection market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Urine Testing Cups Devices: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Urine Testing Cups Market Movement Analysis
  • 7.3. U.S. Urine Testing Cups Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Hospitals & Clinics
    • 7.4.1. Hospitals & clinics market estimates and forecast 2018 to 2030 (USD Million)
  • 7.5. Diagnostic Laboratories
    • 7.5.1. Diagnostic laboratories market estimates and forecast 2018 to 2030 (USD Million)
  • 7.6. Home Use
    • 7.6.1. Home Use market estimates and forecast 2018 to 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. BD
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Abbott
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Labcon North America
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Quest Diagnostics
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Confirm BioSciences
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Alfa Scientific Designs, Inc.
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Medline Industries, LP
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Globe Scientific Inc
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. CLIAWAIVED
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Clarity Diagnostics, LLC
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. SARSTEDT AG & Co. KG
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives
    • 8.2.12. Wondfo
      • 8.2.12.1. Company overview
      • 8.2.12.2. Financial performance
      • 8.2.12.3. Product benchmarking
      • 8.2.12.4. Strategic initiatives
  • 8.3. Company Market Share Analysis, 2024
  • 8.4. List of Other Key Market Players
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦